VXRT - Vaxart 25% spike indicates potential short squeeze

champc/iStock via Getty Images Shares of Vaxart (VXRT) are up more than 25% to $8.97 in afternoon trading, with no news or catalysts, an indication the stock may be in the midst of a short squeeze. Two analysts cover the stock. One has a price target of $13 and the other, $18. Vaxart is one of several companies potentially impacted by an FDA decision late last month that the agency may not grant Emergency Use Authorizations for COVID-19 vaccines if the companies have not yet begun discussions with the regulator.

For further details see:

Vaxart 25% spike indicates potential short squeeze